Investigating the Effects of Mikei® Red Reishi Essence EX on the Immune System of Prostate Cancer Patients and Patients With Non-cancerous Conditions of the Prostate

NCT03589781 · Status: WITHDRAWN · Phase: NA · Type: INTERVENTIONAL

Last updated 2021-03-30

No results posted yet for this study

Summary

The primary objective of this study is to determine the effects of Mikei® Red Reishi Essence EX extract powder on the immune function of prostate cancer patients and patients with non-cancerous conditions of the prostate.

Conditions

Interventions

DIETARY_SUPPLEMENT

Mikei Red Reishi Essence EX

Dosage is 490 mg per capsule, 3 capsules twice a day with food or water. Total of 6 capsules per day.

DIETARY_SUPPLEMENT

Placebo

Matching placebo. Consume 3 capsules twice a day with food or water. Total of 6 capsules per day.

Sponsors & Collaborators

  • Nikkei (Canada) Marketing Limited

    lead INDUSTRY

Principal Investigators

  • Inoel Rivera, MD · Orlando Health Medical Group Urology

  • Qun Huo, Ph.D. · University of Central Florida

Study Design

Allocation
RANDOMIZED
Purpose
PREVENTION
Masking
QUADRUPLE
Model
PARALLEL

Eligibility

Min Age
50 Years
Max Age
85 Years
Sex
MALE
Healthy Volunteers
No

Timeline & Regulatory

Start
2020-11-05
Primary Completion
2021-03-01
Completion
2021-03-01

Countries

  • United States

Study Locations

More Related Trials

Entities

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03589781 on ClinicalTrials.gov